Vimedimex Medi-Pharma JSC (HOSE:VMD)

Vietnam · Delayed Price · Currency is VND

12,400

0.00 (0.00%)

At close: Nov 3, 2026

Vimedimex Medi-Pharma JSC Financials Overview

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Revenue	310,294	812,983	1,249,868	3,536,651	7,073,499	12,318,752
Revenue Growth	-68.76%	-34.96%	-64.66%	-50.00%	-42.58%	-32.17%
Gross Profit	100,678	82,316	118,944	279,256	544,766	1,068,687
Operating Income	79,391	42,716	5,497	35,019	32,149	152,733
Net Income	60,433	42,361	22,016	25,482	34,818	19,995
Earnings Per Share	3913.48	2743.54	1425.89	1650.00	2255.00	1295.00
EPS Growth	75.07%	92.41%	-13.58%	-26.83%	74.13%	-46.10%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Investments	397,010	353,542	335,082	249,455	256,375	179,911
Total Debt	-	-	-	-	-	612,374
Net Cash (Debt)	397,010	353,542	335,082	249,455	256,375	-432,463
Net Cash Growth	12.29%	5.51%	34.33%	-2.70%	-	-
Net Cash Per Share	25711.33	22897.43	21701.83	16152.32	16604.34	-28008.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Operating Cash Flow	-13,409	10,565	118,674	21,872	702,082	-422,016
Capital Expenditures	745.09	-	-7,001	-16,329	-5,163	-20,468
Free Cash Flow	-12,664	10,565	111,673	5,543	696,919	-442,484
Free Cash Flow Growth	-	-90.54%	1914.81%	-99.20%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Gross Margin	32.45%	10.13%	9.52%	7.90%	7.70%	8.67%
Operating Margin	25.59%	5.25%	0.44%	0.99%	0.45%	1.24%
Pretax Margin	30.02%	6.61%	2.45%	1.13%	0.67%	0.23%
Profit Margin	19.48%	5.21%	1.76%	0.72%	0.49%	0.16%
FCF Margin	-4.08%	1.30%	8.94%	0.16%	9.85%	-3.59%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	2000.000	2000.000
Dividend Per Share Growth	0%	-
Dividend Yield	16.13%	12.12%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
PE Ratio	3.17	6.01	11.57	10.30	9.27	27.41
P/FCF Ratio	-	24.12	2.28	47.36	0.46	-
PS Ratio	0.62	0.31	0.20	0.07	0.05	0.04